Shihong Ying

Title: Shihong Ying: Innovator in Cancer Treatment

Introduction

Shihong Ying is a prominent inventor based in Orange, CT (US), known for his significant contributions to the field of cancer treatment. With a total of 4 patents to his name, he has developed innovative compounds that aim to combat hyperproliferative diseases.

Latest Patents

One of his latest patents is focused on Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines, which serve as IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases. This invention relates to novel compounds of formula (I), where the variable groups are defined in the specification and claims. It also includes pharmaceutical compositions containing these compounds and methods of treatment using them for cancer therapy. Another significant patent involves substituted pyrazolyl urea derivatives, which are useful in treating cancer. This invention also relates to compounds of formula (I), pharmaceutical compositions that contain them, and methods for treating cancer using these compounds.

Career Highlights

Shihong Ying has worked with notable companies such as Bayer Healthcare LLC and Bayer Pharmaceuticals Corporation. His work in these organizations has contributed to advancements in pharmaceutical research and development.

Collaborations

He has collaborated with esteemed colleagues, including Gan Wang and Wendy Lee, to further enhance his research and innovations in cancer treatment.

Conclusion

Shihong Ying's work exemplifies the impact of innovative thinking in the medical field, particularly in the fight against cancer. His patents and collaborations reflect a commitment to improving treatment options for patients.